APA

Chowdhury I. H., Choudhuri S., Sen A., Bhattacharya B., Ahmed A. M., Hazra A., Pal N. K. & Bahar B. (20150305). Serum interleukin 6 (IL-6) as a potential biomarker of disease progression in active pulmonary tuberculosis following anti-tuberculosis drug therapy. : Molecular immunology.

Chicago

Chowdhury I H, Choudhuri S, Sen A, Bhattacharya B, Ahmed A M, Hazra A, Pal N K and Bahar B. 20150305. Serum interleukin 6 (IL-6) as a potential biomarker of disease progression in active pulmonary tuberculosis following anti-tuberculosis drug therapy. : Molecular immunology.

Harvard

Chowdhury I. H., Choudhuri S., Sen A., Bhattacharya B., Ahmed A. M., Hazra A., Pal N. K. and Bahar B. (20150305). Serum interleukin 6 (IL-6) as a potential biomarker of disease progression in active pulmonary tuberculosis following anti-tuberculosis drug therapy. : Molecular immunology.

MLA

Chowdhury I H, Choudhuri S, Sen A, Bhattacharya B, Ahmed A M, Hazra A, Pal N K and Bahar B. Serum interleukin 6 (IL-6) as a potential biomarker of disease progression in active pulmonary tuberculosis following anti-tuberculosis drug therapy. : Molecular immunology. 20150305.